KRW 47200.0
(0.21%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | 5.12 Billion KRW | -20.3% |
2022 | 6.42 Billion KRW | -13.91% |
2021 | 7.46 Billion KRW | 48.73% |
2020 | 5.01 Billion KRW | 159.95% |
2019 | 1.93 Billion KRW | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q1 | - KRW | 0.0% |
2024 Q2 | 4.94 Billion KRW | 0.0% |
2023 Q1 | - KRW | -100.0% |
2023 FY | 5.12 Billion KRW | -20.3% |
2023 Q4 | 5.12 Billion KRW | -8.48% |
2023 Q3 | 5.59 Billion KRW | 0.0% |
2022 Q4 | 6.42 Billion KRW | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
HLB Co., Ltd. | 17.93 Billion KRW | 71.446% |
iNtRON Biotechnology, Inc. | 258.29 Million KRW | -1882.471% |
BINEX Co., Ltd. | 5.57 Billion KRW | 8.206% |
Bioneer Corporation | 12.5 Billion KRW | 59.035% |
Anterogen.Co.,Ltd. | - KRW | -Infinity% |
MEDIPOST Co., Ltd. | 6.99 Billion KRW | 26.795% |
CrystalGenomics, Inc. | 29.88 Billion USD | 82.868% |
Helixmith Co., Ltd | 151.68 Million KRW | -3275.937% |
Chabiotech Co.,Ltd. | 95.06 Billion KRW | 94.614% |
Medy-Tox Inc. | 1.22 Billion KRW | -317.723% |
Peptron, Inc. | 4.5 Billion KRW | -13.792% |
Amicogen, Inc. | 70.65 Billion KRW | 92.753% |
Genexine, Inc. | 22.68 Billion KRW | 77.424% |
HLB Therapeutics Co.,Ltd. | 1.84 Billion KRW | -178.266% |
LegoChem Biosciences, Inc. | 528.37 Million KRW | -869.131% |
ALTEOGEN Inc. | 1.24 Billion KRW | -309.893% |
PharmaResearch Co., Ltd. | 970.71 Million KRW | -427.509% |
SillaJen, Inc. | 8.13 Billion KRW | 37.061% |
JETEMA, Co., Ltd. | 60 Billion KRW | 91.466% |
OliX Pharmaceuticals,Inc | 35.36 Billion KRW | 85.519% |
Genomictree Inc. | 97.51 Million KRW | -5151.076% |
MedPacto, Inc. | 1.68 Billion KRW | -203.544% |
EASY BIO,Inc. | 30 Billion KRW | 82.931% |
GI Innovation, Inc. | 2.9 Billion KRW | -76.33% |